The African Centre for Disease Control and World Health Organization have raised the alarm following a drastic uptick in mpox cases. This surge is being driven by a new strain of the virus. Elri Voigt reports about what we know so far and potential implications for South Africa.
With varying degrees of success, artificial intelligence has begun to play the role of research assistant, radiologist, health educator, and even therapist. In this Spotlight special briefing, Jesse Copelyn tries to see past the hype and pin-points the most immediate implications of these new technologies for healthcare in South Africa.
A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.
South Africa is one of only six countries to ever meet their “fair share target” for funding tuberculosis (TB) research, according to a new report. In absolute terms however, South Africa’s contribution is small change compared to investments into TB research made by the top two contributors, the United States government and the Bill and Melinda Gates Foundation. Catherine Tomlinson unpacks what the report tells us about investment in TB research in South Africa.
National Treasury has proposed a R1 billion cut to HIV funding. This has come about because – rather than seeing the reduced price of antiretroviral treatment as an opportunity to scale up treatment coverage and strengthen other interventions to address the HIV epidemic – the Department of Health has seen it as an opportunity for cost-containment. However, the HIV epidemic is not over and savings owing to cost reductions should not simply be returned to Treasury, argue Matshidiso Lencoasa and Mila Harding.
Over the last decade, the National Health Department has rolled out a range of electronic surveillance systems to monitor medicine stocks throughout the country’s healthcare facilities, but stockouts persist due to a host of ongoing challenges. Jesse Copelyn takes a closer look at what is being done to ensure that our clinics and pharmacies do not run out of important medicines.
In the context of weak economic growth, lower-than-expected tax revenues, and the implementation of measures to reduce public spending, there is a “rising panic” ahead of this year’s Medium Term Budget Policy Statement. The concern for health care provision is palpable as anticipated budget cuts threaten the country’s already fragile and understaffed public healthcare system, write Matshidiso Lencoasa and Dominic Brown.
In what is likely one of the largest treatment rollouts in South African history, well over four million people living with HIV have started taking the antiretroviral dolutegravir since its introduction around four years ago. Now, according to a recent study published in the Lancet medical journal, use of dolutegravir in South Africa is associated with more people staying on treatment and higher rates of viral suppression. Elri Voigt unpacks the study findings and assesses progress in the country’s switch to dolutegravir-based HIV treatment.
It is almost three months since – partly through the efforts of SECTION27 and Cancer Alliance – money was made available to the Gauteng Health Department to outsource radiation oncology services and address surgical backlogs in the province. It is deeply worrying that despite being provided with resources for this outsourcing project, very little has been done to date to ensure that patients get the long overdue care that they need, writes Khanyisa Mapipa.
National Health Insurance (NHI) was one of the hot topics at the 2022 Public Health Association of South Africa Conference recently held in Durban. While several speakers and attendees expressed support for the principles underpinning NHI, many also expressed reservations. Elri Voigt assesses what the conference told us about the views of some of South Africa’s public health experts on NHI.
If South Africa wants to strengthen the prevention arm of its HIV programme, which it definitely should, providing comprehensive sex education in schools and training teachers to deliver this curriculum will be vital. It is important that the HIV/AIDS Life Skills Grant, as one of the key pieces of a broader HIV prevention strategy, be supported and strengthened, argue Mbali Baduza and Julia Chaskalson.
Over five million people in South Africa have so far received at least one shot of a COVID-19 vaccine. Elri Voigt unpacks how the vaccination rollout is going in South Africa’s nine provinces. Though the numbers do not tell the full story and provinces face different challenges, indications are that Limpopo, Western Cape, Eastern Cape, and KwaZulu-Natal are doing well, while Mpumalanga is struggling.
